| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/27/2007 | US7183459 Dwf7 mutants |
| 02/27/2007 | US7183458 Isolated nucleic acid sequence; expression cassette of a nucleic acid sequence, a vector and organisms with at least one nucleic acid sequence or expression cassette; unsaturated fatty acids and triglycerides with an increased content of unsaturated fatty acids |
| 02/27/2007 | US7183457 Isolated polynuoleotide with a nucleotide sequence encoding a polypeptide of an Mlo protein and a complement of the nucleotide sequence; nucleic acid fragments encoding disease resistance genes in plants and seed |
| 02/27/2007 | US7183407 High washing efficiency with no contamination and liquid does not remain in the nozzle tip; washing solution is fed into a tip containing the solid phase unidirectionally from head to end |
| 02/27/2007 | US7183406 Method for the synthesis of DNA sequences |
| 02/27/2007 | US7183403 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183398 Developing salt-tolerant crops by means of breeding or genetic engineering |
| 02/27/2007 | US7183397 NK-2 homeobox transcription factor |
| 02/27/2007 | US7183396 Linvin, a novel inhibitor of apoptosis protein |
| 02/27/2007 | US7183395 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same |
| 02/27/2007 | US7183393 Fusion protein of a polypeptide and a heparan sulphate glycosaminoglycan chain which influences binding affinity, binding specificity, and stability; polypeptide of fusion protein can be a cell growth factor, pathogen-related antigen, nuclear protein, cell adhesion molecules, enzyme or enzyme inhibitor |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183380 Use in diagnosing and treating neurological conditions and in identification of compounds that alter IMX97018 polypeptide activities |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183377 Human FRP and fragments thereof including methods for using them |
| 02/27/2007 | US7183376 Variant B7 co-stimulatory molecules |
| 02/27/2007 | US7183262 Administering a construct of a polynucleotide linked to a heat-inducible promoter encoding a therapeutic polypeptide at a site at or near the tumor; and applying heat to the site at or near the tumor to express the polypeptide |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183110 Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase |
| 02/27/2007 | US7183109 Embryo preferred promoter and method of using same |
| 02/27/2007 | US7183107 Enhanced replication of HCV RNA |
| 02/27/2007 | US7183106 Bacterial inosine 5′-monophosphate dehydrogenase (“IMPDH”) DNA as a dominant selectable marker in mammals and other eukaryotes |
| 02/27/2007 | US7183105 Eubacterial minicells and their use as vectors for nucleic acid delivery and expression |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183098 Loline alkaloid gene clusters of the fungal endophyte neotyphodium uncinatum |
| 02/27/2007 | US7183097 Cytotoxin-based biological containment |
| 02/27/2007 | US7183096 Rapid growing microorganisms for biotechnology applications |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183094 Detoxification using amylase; drug screening analysis |
| 02/27/2007 | US7183093 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations |
| 02/27/2007 | US7183092 modified luciferase proteins which are more resistant to inhibition by test chemicals than wild type luciferase |
| 02/27/2007 | US7183090 Laccase enzyme and the gene encoding the enzyme |
| 02/27/2007 | US7183089 Method for enhancing production of isoprenoid compounds |
| 02/27/2007 | US7183087 transformed E. coli comprises a polyhydroxyalkanoate (PHA) synthase gene of Pseudomonas species and lacks a functional fadB gene |
| 02/27/2007 | US7183085 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 02/27/2007 | US7183084 Method for the determination of a nucleic acid using a control |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183080 Cannie IL-5 nucleic acid molecules |
| 02/27/2007 | US7183079 Expression vector comprising synthetic promoter and nucleotide sequences coding cecropin proteins for use as tools to enhance disease resistance in catfish; bactericides; parasiticides |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183077 Promoters and gene expression method by using the promoters |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183070 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders |
| 02/27/2007 | US7183066 Comprises substrate composition for detecting presence of tetanus and botulinum toxoids in neuronal tissues; food poisoning |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183061 Comprises nucleotide sequences coding heliothis ecdysone receptor for controlling gene transcrption in transgenic animal models |
| 02/27/2007 | US7183047 Expression vector for use in the detection of viral proteins |
| 02/27/2007 | US7183002 That selectively bind molecules of interest, especially nucleic acid molecules, under appropriate conditions. Methods of that selectively bind molecules of interest, especially nucleic acid molecules, under appropriate conditions. |
| 02/27/2007 | US7182944 Administering to the subject a nucleic acid encoding a therapeutic agent and a facilitating agent, wherein the nucleic acid encoding a therapeutic agent and the facilitating agent are administered via localized delivery. |
| 02/27/2007 | US7182942 Vaccine immunotherapy for immune suppressed patients |
| 02/27/2007 | US7182916 Method and the device for micro-particle array fabrication |
| 02/27/2007 | CA2293734C Gene screening vector and gene detection method |
| 02/27/2007 | CA2286335C Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies |
| 02/27/2007 | CA2174115C Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms |
| 02/27/2007 | CA2098253C Method for producing ectoprotein of hepatitis c virus |
| 02/25/2007 | CA2517218A1 Marker for psychosis or mood disorder |
| 02/22/2007 | WO2007022506A2 Methods and compositions for treating neurological disease |
| 02/22/2007 | WO2007022470A2 Methods and compositions for treating neurological disease |
| 02/22/2007 | WO2007022416A2 Single chain antibodies against beta-amyloid peptide |
| 02/22/2007 | WO2007022403A2 Ocular gene therapy using avalanche-mediated transfection |
| 02/22/2007 | WO2007022369A2 Chemically modified short interfering nucleic acid molecules that mediate rna interference |
| 02/22/2007 | WO2007022318A2 Nucleic acids and proteins associated with sucrose accumulation in coffee |
| 02/22/2007 | WO2007022195A2 Nitrate transport components |
| 02/22/2007 | WO2007021994A2 Electrode shielding for electroporation |
| 02/22/2007 | WO2007021944A2 In vitro recombination method |
| 02/22/2007 | WO2007021807A1 Mcp1 fusions |
| 02/22/2007 | WO2007021733A2 Methods and compositions for enhancing protein folding |
| 02/22/2007 | WO2007021297A1 COMPOSITIONS OF tRNA AND USES THEREOF |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007021236A1 A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle |
| 02/22/2007 | WO2007021142A1 Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof |
| 02/22/2007 | WO2007021004A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021003A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021002A1 Immunodetection method for influenza virus h5 subtype |
| 02/22/2007 | WO2007020990A1 Gene involved in occurrence/recurrence of hcv-positive hepatocellular carcinoma |
| 02/22/2007 | WO2007020989A1 Sulfate adenyltransferase gene and use thereof |
| 02/22/2007 | WO2007020983A1 Wheat breeding method using genetic map of diploid wheat created by utilizing barley est sequence |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020898A1 Gene involved in silicon uptake and use thereof |
| 02/22/2007 | WO2007020880A1 Method of producing lymphocytes |
| 02/22/2007 | WO2007020873A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection |
| 02/22/2007 | WO2007020853A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein |
| 02/22/2007 | WO2007020847A1 Method for producing cdna and rna chains and nucleotide-immobilized support |
| 02/22/2007 | WO2007020786A1 Gene transfer method specific to trophectodermal cell |
| 02/22/2007 | WO2007020708A1 Method of determining target base included in dna and allele-specific primer to be used in the method |
| 02/22/2007 | WO2007020645A1 Gene silencing of protease activated receptor 1 (par1) |
| 02/22/2007 | WO2007020638A2 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby |
| 02/22/2007 | WO2007020617A2 Sequences of megaplasmid pmp118, chromosomal sequences and individual sequences thereof of lactobacillus salivarius strain ucc118 |
| 02/22/2007 | WO2007020459A2 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 02/22/2007 | WO2007020428A1 Novel peroxidases and uses |
| 02/22/2007 | WO2007020402A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 02/22/2007 | WO2007020295A2 Microorganisms with increased efficiency for methionine synthesis |
| 02/22/2007 | WO2007020290A1 Transglutaminase variants with improved specificity |
| 02/22/2007 | WO2007020244A1 The mitochondrial rhomboid protease parl as a target for lymphoma |
| 02/22/2007 | WO2007020243A2 Vaccine based on virus-neutralizing antibodies |
| 02/22/2007 | WO2007020198A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |